Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.

BACKGROUND: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T3) to prevent I/R renal injury. METHODOLOGY/PRINCIPAL FINDINGS:...

Full description

Bibliographic Details
Main Authors: Carla Ferreyra, Félix Vargas, Isabel Rodríguez-Gómez, Rocío Pérez-Abud, Francisco O'Valle, Antonio Osuna
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3784446?pdf=render
id doaj-3bffbec669b84d5ab19587c3fc78a6eb
record_format Article
spelling doaj-3bffbec669b84d5ab19587c3fc78a6eb2020-11-25T00:47:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7496010.1371/journal.pone.0074960Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.Carla FerreyraFélix VargasIsabel Rodríguez-GómezRocío Pérez-AbudFrancisco O'ValleAntonio OsunaBACKGROUND: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T3) to prevent I/R renal injury. METHODOLOGY/PRINCIPAL FINDINGS: The rats were divided into four groups: sham-operated, placebo-treated (SO-P), sham-operated T3- treated (SO- T3), I/R-injured placebo-treated (IR-P), and I/R-injured T3-treated (IR- T3) groups. At 24 h before ischemia, the animals received a single dose of T3 (100 μg/kg). Renal function and plasma, urinary, and tissue variables were studied at 4, 24, and 48 h of reperfusion, including biochemical, oxidative stress, and inflammation variables, PARP-1 immunohistochemical expression, and ATN morphology. In comparison to the SO groups, the IR-P groups had higher plasma urea and creatinine levels and greater proteinuria (at all reperfusion times) and also showed: increased oxidative stress-related plasma, urinary, and tissue variables; higher plasma levels of IL6 (proinflammatory cytokine); increased glomerular and tubular nuclear PARP-1 expression; and a greater degree of ATN. The IR-T3 group showed a marked reduction in all of these variables, especially at 48 h of reperfusion. No significant differences were observed between SO-P and SO-T3 groups. CONCLUSIONS: This study demonstrates that preconditioning rats with a single dose of T3 improves the clinical signs and ATN of renal I/R injury. These beneficial effects are accompanied by reductions in oxidative stress, inflammation, and renal PARP-1 expression, indicating that this sequence of factors plays an important role in the ATN induced by I/R injury.http://europepmc.org/articles/PMC3784446?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Carla Ferreyra
Félix Vargas
Isabel Rodríguez-Gómez
Rocío Pérez-Abud
Francisco O'Valle
Antonio Osuna
spellingShingle Carla Ferreyra
Félix Vargas
Isabel Rodríguez-Gómez
Rocío Pérez-Abud
Francisco O'Valle
Antonio Osuna
Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
PLoS ONE
author_facet Carla Ferreyra
Félix Vargas
Isabel Rodríguez-Gómez
Rocío Pérez-Abud
Francisco O'Valle
Antonio Osuna
author_sort Carla Ferreyra
title Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
title_short Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
title_full Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
title_fullStr Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
title_full_unstemmed Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
title_sort preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T3) to prevent I/R renal injury. METHODOLOGY/PRINCIPAL FINDINGS: The rats were divided into four groups: sham-operated, placebo-treated (SO-P), sham-operated T3- treated (SO- T3), I/R-injured placebo-treated (IR-P), and I/R-injured T3-treated (IR- T3) groups. At 24 h before ischemia, the animals received a single dose of T3 (100 μg/kg). Renal function and plasma, urinary, and tissue variables were studied at 4, 24, and 48 h of reperfusion, including biochemical, oxidative stress, and inflammation variables, PARP-1 immunohistochemical expression, and ATN morphology. In comparison to the SO groups, the IR-P groups had higher plasma urea and creatinine levels and greater proteinuria (at all reperfusion times) and also showed: increased oxidative stress-related plasma, urinary, and tissue variables; higher plasma levels of IL6 (proinflammatory cytokine); increased glomerular and tubular nuclear PARP-1 expression; and a greater degree of ATN. The IR-T3 group showed a marked reduction in all of these variables, especially at 48 h of reperfusion. No significant differences were observed between SO-P and SO-T3 groups. CONCLUSIONS: This study demonstrates that preconditioning rats with a single dose of T3 improves the clinical signs and ATN of renal I/R injury. These beneficial effects are accompanied by reductions in oxidative stress, inflammation, and renal PARP-1 expression, indicating that this sequence of factors plays an important role in the ATN induced by I/R injury.
url http://europepmc.org/articles/PMC3784446?pdf=render
work_keys_str_mv AT carlaferreyra preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats
AT felixvargas preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats
AT isabelrodriguezgomez preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats
AT rocioperezabud preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats
AT franciscoovalle preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats
AT antonioosuna preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats
_version_ 1725259988202422272